Export 692 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
K. C Kim, Lee, Y. Rui, Ong, L., Gold, M., Kalali, A., and Sarkar, J., Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures., J Alzheimers Dis, vol. 87, no. 1, pp. 83-100, 2022.
R. C. Petersen, Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., and Weiner, M. W., Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization., Neurology, vol. 74, no. 3, pp. 201-9, 2010.
C. Ferrari, Lombardi, G., Polito, C., Lucidi, G., Bagnoli, S., Piaceri, I., Nacmias, B., Berti, V., Rizzuto, D., Fratiglioni, L., and Sorbi, S., Alzheimer's Disease Progression: Factors Influencing Cognitive Decline., J Alzheimers Dis, vol. 61, no. 2, pp. 785-791, 2018.
D. Zádori, Veres, G., Szalárdy, L., Klivenyi, P., and Vecsei, L., Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines., J Alzheimers Dis, vol. 62, no. 2, pp. 523-547, 2018.
A. Griciuc, Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. Hoon, Hyman, B. T., and Tanzi, R. E., Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta., Neuron, vol. 78, no. 4, pp. 631-43, 2013.
G. Liu, Zhang, Y., Wang, L., Xu, J., Chen, X., Bao, Y., Hu, Y., Jin, S., Tian, R., Bai, W., Zhou, W., Wang, T., Han, Z., Zong, J., and Jiang, Q., Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood., J Alzheimers Dis, vol. 61, no. 3, pp. 1077-1088, 2018.
S. Hatashita and Wakebe, D., Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging., J Alzheimers Dis, vol. 57, no. 3, pp. 765-773, 2017.
F. Wang, Xu, J., Xu, S. - J., Guo, J. - J., Wang, F., and Wang, Q. - W., Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics., J Alzheimers Dis, vol. 85, no. 2, pp. 729-744, 2022.
B. A. Ardekani, Convit, A., and Bachman, A. H., Analysis of the MIRIAD Data Shows Sex Differences in Hippocampal Atrophy Progression., J Alzheimers Dis, vol. 50, no. 3, pp. 847-57, 2016.
M. Dlugaj, Winkler, A., Weimar, C., Dürig, J., Broecker-Preuss, M., Dragano, N., Moebus, S., Jöckel, K. - H., Erbel, R., and Eisele, L., Anemia and Mild Cognitive Impairment in the German General Population., J Alzheimers Dis, vol. 49, no. 4, pp. 1031-42, 2016.
C. Birkenbihl, Westwood, S., Shi, L., Nevado-Holgado, A., Westman, E., Lovestone, S., and Hofmann-Apitius, M., ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset., J Alzheimers Dis, vol. 79, no. 1, pp. 423-431, 2021.
T. G. Beach, Maarouf, C. L., Intorcia, A., Sue, L. I., Serrano, G. E., Lu, M., Joshi, A., Pontecorvo, M. J., and Roher, A. E., Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Aβ42 but not Aβ40., J Alzheimers Dis, vol. 61, no. 4, pp. 1509-1516, 2018.
A. Belkacemi and Ramassamy, C., Anthocyanins Protect SK-N-SH Cells Against Acrolein-Induced Toxicity by Preserving the Cellular Redox State., J Alzheimers Dis, vol. 50, no. 4, pp. 981-98, 2016.
F. Piazza, Greenberg, S. M., Savoiardo, M., Gardinetti, M., Chiapparini, L., Raicher, I., Nitrini, R., Sakaguchi, H., Brioschi, M., Billo, G., Colombo, A., Lanzani, F., Piscosquito, G., Carriero, M. Rita, Giaccone, G., Tagliavini, F., Ferrarese, C., and DiFrancesco, J. C., Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies., Ann Neurol, vol. 73, no. 4, pp. 449-58, 2013.
A. Hatami, Monjazeb, S., and Glabe, C., The Anti-Amyloid-β Monoclonal Antibody 4G8 Recognizes a Generic Sequence-Independent Epitope Associated with α-Synuclein and Islet Amyloid Polypeptide Amyloid Fibrils., J Alzheimers Dis, vol. 50, no. 2, pp. 517-25, 2016.
J. Bastrup, Hansen, K. H., Poulsen, T. B. G., Kastaniegaard, K., Asuni, A. A., Christensen, S., Belling, D., Helboe, L., Stensballe, A., and Volbracht, C., Anti-Aβ Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 79, no. 1, pp. 249-265, 2021.
T. E. Golde, Schneider, L. S., and Koo, E. H., Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift., Neuron, vol. 69, no. 2, pp. 203-13, 2011.
J. J. Gomar, Conejero-Goldberg, C., Davies, P., and Goldberg, T. E., Anti-Correlated Cerebrospinal Fluid Biomarker Trajectories in Preclinical Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1085-97, 2016.
I. Liampas, Hatzimanolis, A., Siokas, V., Yannakoulia, M., Kosmidis, M. H., Sakka, P., Hadjigeorgiou, G. M., Scarmeas, N., and Dardiotis, E., Antihypertensive Medication Class and the Risk of Dementia and Cognitive Decline in Older Adults: A Secondary Analysis of the Prospective HELIAD Cohort., J Alzheimers Dis, vol. 89, no. 2, pp. 709-719, 2022.
S. A. Chau, Chung, J., Herrmann, N., Eizenman, M., and Lanctôt, K. L., Apathy and Attentional Biases in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 837-46, 2016.
J. R. Burrell, Ballard, K. J., Halliday, G. M., and Hodges, J. R., Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia., J Alzheimers Dis, vol. 61, no. 2, pp. 705-715, 2018.
J. C. Morris, Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., and Mintun, M. A., APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging., Ann Neurol, vol. 67, no. 1, pp. 122-31, 2010.
M. Berger, Cooter, M., Roesler, A. S., Chung, S., Park, J., Modliszewski, J. L., VanDusen, K. W., J Thompson, W., Moseley, A., Devinney, M. J., Smani, S., Hall, A., Cai, V., Browndyke, J. N., Lutz, M. W., and Corcoran, D. L., APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid., J Alzheimers Dis, vol. 79, no. 2, pp. 511-530, 2021.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.